Nu Skin Enterprises, Inc. 在全球開發及分銷健康與個人護理產品。公司總部位於猶他州普羅沃。
財務指標
營業收入
2026-06-30
$320.11M
2026-03-31
$320.6M
2025-12-31
$370.32M
2025-09-30
$364.21M
營業支出
2026-06-30
$277.64M
2026-03-31
$208.59M
2025-12-31
$238.73M
2025-09-30
$235.08M
淨利潤
2026-06-30
-$249.79M
2026-03-31
$1.83M
2025-12-31
$14.49M
2025-09-30
$17.07M
淨利潤率
2026-06-30
-78.03%
2026-03-31
0.57%
2025-12-31
3.91%
2025-09-30
4.68%
每股收益
2026-06-30
$0.20
2026-03-31
$0.14
2025-12-31
$0.29
2025-09-30
$0.34
息稅折舊攤銷前利潤
2026-06-30
-$47.19M
2026-03-31
$19.19M
2025-12-31
$35.09M
2025-09-30
$32.23M
有效稅率
2026-06-30
-295.4%
2026-03-31
29.35%
2025-12-31
20.33%
2025-09-30
-6.78%
項目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
營業收入
$320.11M
$320.6M
$370.32M
$364.21M
營業支出
$277.64M
$208.59M
$238.73M
$235.08M
淨利潤
-$249.79M
$1.83M
$14.49M
$17.07M
淨利潤率
-78.03%
0.57%
3.91%
4.68%
每股收益
$0.20
$0.14
$0.29
$0.34
息稅折舊攤銷前利潤
-$47.19M
$19.19M
$35.09M
$32.23M
有效稅率
-295.4%
29.35%
20.33%
-6.78%
常見問題
NUS represents Nu Skin Enterprises, a company focused on personal care and wellness products. It develops and sells skincare, nutritional supplements, and related items, primarily through a direct-selling model. Its products are marketed globally via a network of independent distributors, and the company also operates in the beauty and wellness technology space. For a full description of its business segments and product lines, refer to the company profile on the NUS stock page.
Several factors can influence NUS stock, including changes in consumer demand for wellness and beauty products, distributor productivity, foreign exchange fluctuations, and competition from other direct-selling and e-commerce brands. Regulatory developments in key markets, supply chain disruptions, and broader economic conditions may also play a role. Company-specific events such as earnings releases, guidance updates, and management changes can affect investor sentiment. For the latest NUS-specific developments, check the news and analysis sections on the stock page.
Recent performance for NUS can be found in the price chart and performance summary displayed on this page. Stock returns over various periods depend on factors such as quarterly results, forward guidance, and market conditions. The page typically shows the latest price, daily change, and historical returns. For the most current data, refer to the NUS quote and performance section, as prices change frequently during market hours.
Valuation for NUS can be assessed using metrics such as the price-to-earnings ratio, price-to-sales ratio, and enterprise value multiples. Comparing these ratios to peers in the personal products and direct-selling industry provides context. Analysts also consider growth rates, profit margins, and return on equity. The NUS stock page may display current valuation ratios and comparisons to help frame whether the stock appears richly or modestly valued relative to its history or sector.
Nu Skin Enterprises has historically paid dividends, though the amount and frequency can change based on company policy and financial performance. The current dividend status, yield, and payment schedule are shown on the NUS stock page under the dividend section. Investors often review the payout ratio and free cash flow to assess dividend sustainability. For the latest declared dividend, ex-dividend date, and yield, refer to the data displayed on this page.
Key risks for NUS include reliance on independent distributors, regulatory scrutiny of direct-selling practices, and intense competition in the wellness and beauty markets. Currency fluctuations can affect international revenue, and economic downturns may reduce discretionary spending on premium products. Additionally, changes in consumer preferences and supply chain challenges could impact results. These risks are detailed in the company's SEC filings, and investors should review the risk factors section of the latest annual report for a comprehensive overview.